September 16, 2014

Funding opportunities from the CDMRP for breast cancer and Alzheimer's research

1. FY14 DOD Peer Reviewed Alzheimer’s Research Program Announcements

The following Fiscal Year 2014 (FY14) Department of Defense (DOD) funding opportunity being managed by the office of the Congressionally Directed Medical Research Programs (CDMRP).

Peer Reviewed Alzheimer’s Research Program

  • Convergence Science Research Award
  • Quality of Life Research Award
  • Military Risk Factors Research Award

Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcement. The Program Announcement is available electronically for downloading from the Grants.gov website (http://www.grants.gov), the CDMRP website (http://cdmrp.army.mil/funding/prgdefault.shtml) and the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org).

 

2. Defense Health Program Department of Defense Breast Cancer Research Program

The Fiscal Year 2014 (FY14) Defense Appropriations Act provides $120 million (M) to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact breast cancer research. The BCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

FY14 BCRP Program Announcements and General Application Instructions for the Breakthrough Award are posted on Grants.gov.

Breakthrough Award – Key Features.

  • Supports promising research that has the potential to lead to or make breakthroughs in breast cancer.
  • Potential impact of the research may be near-term or long-term, but it must be significant and go beyond an incremental advancement.
  • Partnering PI Option allows two PIs, termed Initiating and Partnering PIs, to collaborate on a single application.
  • Four different funding levels, based on the scope of research, are available. It is the responsibility of the PI to select the funding level that is most appropriate for the research proposed.
    • Funding Level 1: Maximum funding of $350,000 for direct costs (plus indirect costs) for up to 3 years.
    • Funding Level 2: Maximum funding of $700,000 for direct costs (plus indirect costs) for up to 3 years.
    • Funding Level 3: Maximum funding of $2.5M for direct costs (plus indirect costs) for up to 5 years.
    • Funding Level 4: Maximum funding of $10M for direct costs (plus indirect costs) for up to 5 years.

Funding Levels 1 and 2 - Letter of intent is due December 3, 2014; Full applications are due December 17, 2014

  • Eligibility: Investigators at all academic levels (or equivalent).
  • Postdoctoral fellows are eligible to submit.
  • Submission of a Letter of Intent is required prior to full application submission.
  • Each PI may submit only one application as a single PI or Initiating PI.
  • Clinical trials are not allowed.
  • Applications are encouraged, but not required, to include breast cancer advocate involvement.

Funding Levels 3 and 4 - Preproposal is due October 22, 2014; Full applications are due January 29, 2015

  • Eligibility: Independent investigators at all academic levels (or equivalent).
  • Submission of a preproposal is required; application submission is by invitation only.
  • Each PI may submit only one application as a single PI or Initiating PI.
  • Clinical trials are allowed.
  • Applications are required to include two or more breast cancer advocates.

All applications must conform to the Program Announcements and General Application Instructions that are available for electronic downloading from the Grants.gov website. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

 

Share